13 agosto 2015
Findings of a new study introduce new drug targets to selectively inhibit a key event in tumor cell progression. The study provides further insight into the control of mTORC1 activation, and highlights several new potential drug targets to treat human pathologies linked to mTORC1 deregulation.
http://www.sciencedaily.com/releases/2015/08/150813130451.htm
